<DOC>
	<DOCNO>NCT01676116</DOCNO>
	<brief_summary>This trial conduct Europe , Oceania United States America ( USA ) . The aim trial investigate efficacy insulin degludec/liraglutide control glycaemia adult type 2 diabetes inadequately control glucagon-like peptide-1 ( GLP-1 ) receptor agonist OAD therapy .</brief_summary>
	<brief_title>The Efficacy Insulin Degludec/Liraglutide Controlling Glycaemia Adults With Type 2 Diabetes Inadequately Controlled GLP-1 Receptor Agonist OAD Therapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Subjects type 2 diabetes mellitus Glycosylated haemoglobin ( HbA1c ) 7.09.0 % ( 5375 mmol/mol ) ( inclusive ) Treatment daily GLP1 receptor agonist maximum dose accord local label ( i.e . 1.8 mg daily ( OD ) Victoza速 ( liraglutide ) 10 microgram twice daily ( BID ) Byetta速 ( exenatide ) ) document maximum tolerate dose ( i.e . 1.2 mg OD Victoza速 ( liraglutide ) 5 microgram BID Byetta速 ( exenatide ) ) combination stable daily dose metformin ( equal 1500 mg document maximum tolerated dose ) 90 day prior screen visit ( Visit 1 ) BMI ( body mass index ) equal 40 kg/m^2 Any use oral antidiabetic drug ( OADs ) ( except metformin , pioglitazone sulphonylurea ) 90 day less prior screen visit ( Visit 1 ) Use drug ( except metformin , pioglitazone , sulphonylurea GLP1 receptor agonist ) Investigator 's opinion could interfere blood glucose level ( e.g . systemic corticosteroid ) Treatment insulin regimen ( short term treatment due intercurrent illness include gestational diabetes allow discretion Investigator ) Screening calcitonin equal 50 ng/l Personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia type 2 ( MEN2 ) Cardiovascular disorder define : congestive heart failure ( New York Heart Association ( NYHA ) class IIIIV ) , diagnosis unstable angina pectoris , cerebral stroke and/or myocardial infarction within past 52 week prior screen visit ( Visit 1 ) and/or plan coronary , carotid peripheral artery revascularisation procedure Proliferative retinopathy require acute treatment maculopathy ( macular oedema ) accord Investigator 's opinion Subjects clinically significant , active ( past 12 month ) disease gastrointestinal , pulmonary , endocrinological ( except type 2 diabetes mellitus ) , neurological , genitourinary haematological system opinion Investigator may confound result trial pose additional risk administer trial product History chronic pancreatitis idiopathic acute pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>